Panakeia’s proprietary AI-driven software provides molecular biomarker (genetic, protein etc.) information in minutes instead of days or weeks. Panakeia does this by rapid analysis by analyses of routinely used tissue images, without needing wet-lab assays. The speed of Panakeia’s solutions has the potential to save lives by accelerating drug development for biopharma and enabling 1-day turnaround time for treatment decision-making.